Complete Remission of Rectal Cancer Using a New Immunotherapy Method
Rectal cancer disappeared in all patients who participated in a small clinical trial of a new immunotherapy method, according to results published this month. The research was carried out in cooperation with the American Memorial Sloan Kettering (MSK) oncology center and the pharmaceutical company GSK. A new drug, dostarlimab-gxly, was tested for the treatment of…